News EN

4th Swiss Autoimmune Liver Disease Meeting September 21st-22nd, Lugano, Switzerland

By Swiss HePa / January 26, 2023 /
Fondazione Epatocentro Ticino 4th Swiss Autoimmune Liver Disease Meeting September 21st- 22nd 2023, USI Università della Svizzera Italiana, Aula Magna, Lugano, Switzerland

The two-day event will be held in Lugano, in English. It is mainly aimed at doctors. However, patient and self-help representatives are welcome and can attend free of charge. On the first day, there will be a session for patient representatives in the morning (also in English). It is not yet known whether digital participation will also be possible.

read more...

AIH patient survey regarding COVID-19

By Swiss HePa / September 7, 2022 /
ERN Rare Liver

To get a broader overview of the situation of patients with AIH, we have created an anonymous and patient-oriented online survey in several languages for patients with AIH.
We would be pleased if you as an AIH patient could support us with your answers to the survey.

read more...

Herbal and Dietary Supplements Induced Liver Injury: Interview with PD. Dr. med. Christoph Jüngst

By Swiss HePa / May 9, 2022 /
Herbal and Dietary Supplements Induced Liver Injury: Interview with PD. Dr. med. Christoph Jüngst

“What is liver damage by herbal and dietary supplements (HDS)?” Dr. Jüngst makes it clear to us that HDS can also cause liver inflammation and liver damage. That is why a doctor-patient relationship of trust with a comprehensive exchange of information and personal responsibility is very important. You are welcome to report experience of this to Swissmedic.

read more...

Herbal and Dietary Supplements Induced Liver Injury: Presentation by PD. Dr. med. Christoph Jüngst

By Swiss HePa / May 9, 2022 /
Herbal and Dietary Supplements Induced Liver Injury: Presentation by PD. Dr. med. Christoph Jüngst

“How often is liver damage caused by herbal and dietary supplements (HDS)?” Dr Jüngst impressively describes the increase in the prevalence of liver damage caused by HDS, the frequency due to the products offered (internet), causes, diagnoses, course and therapies, as well as the difficulties of proof: That is why a report to Swissmedic is important!

read more...

Liver Toxicity by Mushroom Intoxication: Interview with PD. Dr. med. Christoph Jüngst

By Swiss HePa / May 2, 2022 /
Liver Toxicity by Mushroom Intoxication: Interview with PD. Dr. med. Christoph Jüngst

“What are death cap mushrooms?” Dr Jüngst explains to us that the lamellar fungus is characterised by a certain extreme toxin. This means calling Tox Info Suisse 145 in case of suspicion or immediately going to the nearest emergency room in case of acute symptoms!

read more...

Liver Toxicity by Mushroom Intoxication: Presentation by PD. Dr. med. Christoph Jüngst

By Swiss HePa / May 2, 2022 /
Liver Toxicity by Mushroom Intoxication: Presentation by PD. Dr. med. Christoph Jüngst

“How dangerous is death cap mushroom poisoning?” Dr. Jüngst impressively describes this highly poisonous lamellar fungus and the life-threatening consequences, which require rapid action: Therefore, call the emergency room or Tox Info Suisse 145 immediately!

read more...

Drug-Induced Liver Injury (DILI): Interview with PD. Dr. med. Christoph Jüngst

By Swiss HePa / April 25, 2022 /
Drug-Induced Liver Injury (DILI): Interview with PD. Dr. med. Christoph Jüngst

“What is drug-induced liver injury (DILI)?” DILI is rare, but more common than thought, as more and more studies show, Dr Jüngst confirms to us. Key for the right therapy are diagnosis, exclusion diagnosis, the DILI – prognosis (e.g. by Hy’s Law) and the determination of risk factors. It is recommended to first discuss a corresponding notification to Swissmedic with the attending physician.

read more...

Drug-Induced Liver Injury (DILI): Presentation by PD. Dr. med. Christoph Jüngst

By Swiss HePa / April 25, 2022 /
Drug-Induced Liver Injury (DILI): Presentation by PD. Dr. med. Christoph Jüngst

“What is drug-induced liver injury (DILI)?” Dr Jüngst distinguishes between two categories of DILI, namely overdose and hypersensitivity reactions. Frequency and severe symptoms further indicate the importance of good consultation with the GP and personal responsibility with medications.

read more...

Outcome4medicine – Consensus Conference in Zurich

By Swiss HePa / April 24, 2022 /
OUTCOME4MEDICINE Consesus Converence in Zurich

8th – 10th June 2022
Defining quality in surgery to improve patient care worldwide

read more...

USZ Symposium of the 1000th liver transplantation, on 28.04.2022

By Swiss HePa / April 19, 2022 /
Symposium: 1000th Liver Transplant in Zurich

Dear patients, relatives and interested parties, On Thursday afternoon, 28.04.2022, from 13:30, a symposium will be held at the USZ on the occasion of the 1000th liver transplant. You will find the programme below as a download (PDF), the presentations are partly in English, partly in German. In addition to specialists from the medical field,…

read more...